Harmony Biosciences Investors

34 investors on Angel Roster list Harmony Biosciences in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Series B and the largest groups are based in the United States, China and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name Harmony Biosciences can appear together.

Investors listed
34
With verified email
50%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 34 Harmony Biosciences investors

The most complete profiles first. Showing 34 of 34.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Adam WhiteheadVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Ben WessnerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian EnglanderVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Dylan HarmonVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Scott LiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Todd HolmesVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Justin Waney

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Luke Duster

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nate Hukill

    Venture Capital, Private Equity Firm · Puerto Rico

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Sami Hawwa

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Zain Shekhani

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

Frequently asked questions

How many Harmony Biosciences investors are on Angel Roster?

Angel Roster lists 34 Harmony Biosciences investors. 17 of them (50%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (34), Venture Capital Firms (22) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Harmony Biosciences investors invest in?

Among those that list a stage, the most common are Series B (7), Seed (6) and Series A (5).

Where are Harmony Biosciences investors based?

Most are based in the United States (27), China (3) and Israel (2).

Which companies have Harmony Biosciences investors backed?

The most-backed portfolio companies among them are Ventyx Biosciences (23), Arcutis Biotherapeutics (18), Remegen (18), Passage Bio (18) and Gracell Biotechnologies (18).

How do I contact Harmony Biosciences investors?

Create a free Angel Roster account to search and filter all 34, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.